ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0493

MRI Is Superior to Ultrasound of Supraaortic Arteries in Detecting Giant Cell Arteritis – Experience of a Single Center

Matthias Froehlich1, Thorsten A. Bley2, Marc Schmalzing3, Michael Gernert1, Rudolf A. Werner4, Jost Hillenkamp5, Karl Georg Haeusler6 and Konstanze V. Guggenberger2, 1University Hospital Wuerzburg, Dpt. of Internal Medicine II, Wuerzburg, Germany, 2University Hospital Wuerzburg, Dpt. of Radiology, Wuerzburg, Germany, 3University Hospital Wuerzburg, Wuerzburg, Germany, 4University Hospital Wuerzburg, Dpt. of Nuclear medicine, Wuerzburg, Germany, 5University Hospital Wuerzburg, Dpt. of Ophtalmology, Wuerzburg, Germany, 6University Hospital Wuerzburg, Dpt. of Neurology, Wuerzburg, Germany

Meeting: ACR Convergence 2022

Keywords: giant cell arteritis, Imaging, Magnetic resonance imaging (MRI), Ultrasound, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Vasculitis – Non-ANCA-Associated and Related Disorders Poster I: Giant Cell Arteritis

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Imaging techniques for the detection of mural inflammation are cornerstones in the diagnosis of giant cell arteritis (GCA). Magnetic resonance imaging (MRI) and ultrasound are central in this regard, but data comparing both methods are scarce.

Methods: Case-control study of 88 patients (mean age 70±9.6 years, 64% women), 44 with GCA and 44 with initial suspicion of GCA who finally did not have GCA. The standardized 3 Tesla MRI protocol included the temporal, occipital, vertebral, carotid, subclavian, and axillary arteries, the thoracic and abdominal aorta including the renal arteries. The standardized ultrasound protocol included the temporal, carotid, and axillary arteries using a linear array transducer at 18 MHz. Trained MRI and ultrasound diagnosticians blinded to other diagnostic findings or clinical data. Correctness of the GCA diagnosis was prospectively confirmed by the Rheumatology Department after 3 months by clinical examination.

Results: Overall, 44 patients with GCA (37 at initial diagnosis and 7 at GCA-relapse) and 44 controls were examined. MRI and ultrasound were performed on the same day in 81 patients. Time difference between MRI and ultrasound was median 0 (IQR 0) days. At the time of investigation, 21 of 44 GCA patients were therapy-naïve.

Ultrasound detected signs of vasculitis in 20 of 44 GCA patients (sensitivity 45%). In patients with supraaortic GCA, 20 of 34 (sensitivity 59%) patients were identified to have GCA. In patients on steroids (duration mean 60 days (IQR 67 days), ultrasound identified 11 of 23 patients (sensitivity 48%) to have GCA. The sensitivity of MRI was 73% (32 of 44 GCA patients), demonstrated occipital artery vasculitis in 22 of 44 patients. In supraaortic GCA, 27 of 34 (sensitivity 79% patients were identified by MRI.

In comparison, MRI diagnosed 13 additionally arteritis patients compared to ultrasound. Of those, arteritis was found in the thoracic aorta (n=3), the abdominal aorta (n=4), occipital artery (n=3), and vertebral artery (n=2) or combinations thereof. In 5 patients, ultrasound did not reveal vasculitis-typical findings, although they were detectable on MRI.

In the control group, all 44 patients were negative for vessel wall inflammation on both, MRI and ultrasound (specificity 100%). The main diagnoses in the control group were polymyalgia rheumatica (n=21), and non-arteritic anterior ischemic optic neuropathy (n=20).

Conclusion: MRI is superior to ultrasound in detecting inflammatory activity in GCA as more vessels are examined and evaluation of MRI is more sensitive. Involvement of occipital arteries is a common manifestation in GCA that is neither easily detectable by ultrasound nor readily amenable to biopsy but can be detected by MRI. Involvement of aorta and its branches is also common, which, with the exception of axillary arteries, cannot be recorded structurally in US.


Disclosures: M. Froehlich, None; T. Bley, None; M. Schmalzing, Novartis, AbbVie, AstraZeneca, Chugai/Roche, Janssen, Gilead, Boehringer/Ingelheim, Celgene, Medac, UCB, Sandoz; M. Gernert, None; R. Werner, None; J. Hillenkamp, None; K. Haeusler, None; K. Guggenberger, None.

To cite this abstract in AMA style:

Froehlich M, Bley T, Schmalzing M, Gernert M, Werner R, Hillenkamp J, Haeusler K, Guggenberger K. MRI Is Superior to Ultrasound of Supraaortic Arteries in Detecting Giant Cell Arteritis – Experience of a Single Center [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/mri-is-superior-to-ultrasound-of-supraaortic-arteries-in-detecting-giant-cell-arteritis-experience-of-a-single-center/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mri-is-superior-to-ultrasound-of-supraaortic-arteries-in-detecting-giant-cell-arteritis-experience-of-a-single-center/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology